Postoperative Pain, Postoperative Pain Management
Conditions
Keywords
pupillometry, automated pupillometry, post-operative pain, post-operative opiod consumption
Brief summary
Effective intraoperative and postoperative pain management is critical for patient comfort and recovery, yet traditional methods for assessing pain under general anaesthesia are limited by their subjective nature and reliance on vital signs. Automated pupillometry, which gives the parameters of the pupillary light reflex (PLR) components, offers an objective and quantitative approach to evaluating nociception and pain. This study aims to evaluate the effectiveness of the automated pupillometry in enhancing early postoperative pain control and to assess its utility in guiding opioid administration during the perioperative period. A prospective, non-blinded randomized controlled trial will be conducted with 68 patients undergoing laparotomy for gastrointestinal surgery. Participants will be randomly assigned to either an interventional group, where analgesia is guided by automated pupillometry measurements, or a control group receiving standard pain management. Key outcomes include the time to first rescue analgesia, self-reported pain scores, opioid consumption. The automated pupillometry measurements will be taken at key surgical moments, including before induction, pre-incision, and during recovery. Pain scores and rescue analgesia use will be compared between groups using appropriate statistical tests, and Kaplan-Meier survival curves will analyze time to first rescue analgesia. Regression analyses will explore the relationship between pupillometry readings and postoperative pain. It is anticipated that the automated pupillometry guided group will experience longer intervals before requiring rescue analgesia and report lower pain scores, suggesting improved pain management and reduced opioid use. This study could validate automated pupillometry as an innovative tool for optimizing postoperative pain management, potentially improving patient outcomes by enabling more precise and effective analgesia in surgical settings.
Interventions
DRUGOpioid Analgesic
Participants in the interventional group will receive an initial dose of 100 mcg IV fentanyl during induction. Remifentanil will be administered via effect-site target-controlled infusion (TCI), with a concentration effect (Ce) ranging from 2 to 8 ng/ml. TCI remifentanil is increased by 0.5 ng/ml if pupillary diameter changes \> 20% of the baseline after induction. The automated pupillometry measurement is repeated 5 mins after increment. Prior to skin closing, IV morphine 0.1 mg/kg during skin closing and automated pupillometry measurement is repeated to aim pupillary diameter is within 20% of baseline. Analgesics is titrated according to the anaesthetist's discretion and reason is documented if it is deviated from the protocol.
DEVICEautomated pupillometry
For both arms, automated pupillometry will be measured before induction , after induction(baseline), before the surgical incision, after surgical incision, during skin closure, at PACU 10 mins and at PACU 30 mins. For intervention arm only, the additional automated pupillometry measurement will be performed after administration of analgesia.
Sponsors
University of Malaya
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
prospective, pragmatic, randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* 1\. Patients aged 18 - 70 years old scheduled for elective/emergency laparotomy with clear awareness and good communication * 2\. ASA (American Society of Anaesthesiologists) physical status I-III * 3\. Expected to have moderate to severe pain in the early postoperative period
Exclusion criteria
* 1\. Patient with known pupillary abnormality (such as anisocoria, pharmacologic dilation, previous intraocular surgery) * 2\. Pre-existing neurological disorder affecting pupillary reflexes * 3\. Patients on chronic opioid therapy or with a history of substance abuse * 4\. Non-consenting patients or those with cognitive impairments affecting informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| post operative opioid consumption | first 24 hours post operatively | the amount of post operative opioid consumption including rescue analgesia and patient controlled analgesia morphine usage would be recorded |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The correlation between pupillary response metrics (% change, constriction velocity, dilatation velocity, NPi) and opioid dosage administered. | automated pupillometry measurements will be done before induction, after induction, before skin incision, during skin incision, after skin incision, during skin closure, and at post anaesthesia recovery unit 10 min and 30 min. | To find the measurement changes or correlation with opioiod administration, and to analyse it statistically |
Countries
Malaysia
Outcome results
None listed